本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

维罗纳制药

105.09
-0.2100-0.20%
成交量:420.79万
成交额:4.43亿
市值:89.47亿
市盈率:-52.08
高:105.28
开:105.17
低:105.02
收:105.30
数据加载中...
2025/01/07

重要事件披露

Form 8-K - Current report
2024/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/04

重要事件披露

Form 8-K - Current report
2024/10/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/28

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report